- Home
- HRMY vs UPWK Comparison
HRMY vs UPWK Comparison
Compare HRMY & UPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HRMY | UPWK |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HRMY | UPWK |
|---|---|---|
| Price | $35.24 | $19.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $50.56 | $21.85 |
| AVG Volume (30 Days) | 934.4K | ★ 5.6M |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.44 | ★ 179.51 |
| EPS | ★ 3.17 | 1.74 |
| Revenue | ★ $825,944,000.00 | $780,858,000.00 |
| Revenue This Year | $20.68 | $2.52 |
| Revenue Next Year | $15.93 | $5.36 |
| P/E Ratio | ★ $11.14 | $11.37 |
| Revenue Growth | ★ 21.13 | 2.50 |
| 52 Week Low | $25.52 | $11.13 |
| 52 Week High | $40.93 | $20.54 |
Technical Indicators
Market Signals| Indicator | HRMY | UPWK |
|---|---|---|
| Relative Strength Index (RSI) | 71.09 | 63.39 |
| Support Level | $32.77 | $19.05 |
| Resistance Level | $36.20 | $20.19 |
| Average True Range (ATR) | 1.11 | 1.01 |
| MACD | 0.17 | 0.31 |
| Stochastic Oscillator | 81.04 | 88.21 |
Price Performance
Historical ComparisonAbout HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.